Barr Evaluates BTK Inhibitors for Treating Frontline CLLAugust 29th 2020
During a virtual Case Based Peer Perspectives event, Paul M. Barr, MD, reviewed the case of a 71-year-old woman with newly diagnosed chronic lymphocytic leukemia and the role of BTK inhibitors in the frontline setting.
McCloskey Explores Merits of Targeted Treatments and HMAs in MDSAugust 23rd 2020
The options for targeted therapy and treatment with hypomethylating agents was discussed during a virtual Case Based Peer Perspectives event, which highlighted the case of a 75-year-old male patient with myelodysplastic syndromes. The discussion was led by James K. McCloskey II, MD.
Coutre Evaluates Treatment Options in Relapsed/Refractory CLLAugust 13th 2020
During a virtual Case Based Peer Perspectives event, Steven Coutre, MD, reviewed a case of a 53-year-old woman who first presented with elevated white blood cell count. The patient was later diagnosed with chronic lymphocytic leukemia.